This randomized phase II trial studies the effects of aspirin and zileuton on genes related
to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to
tobacco use and may be useful in preventing lung cancer in current smokers.
Intervention
Aspirin, Laboratory Biomarker Analysis, Zileuton, Placebo Administration
Condition
Tobacco Use Disorder
Investigators
Linda L Garland